Your Annual Hepatitis C Update


Hepatitis C virus (HCV) is the most common bloodborne pathogen in the United States, with baby boomers accounting for nearly half of the more than 4 million individuals chronically infected nationwide. Notably, three-quarters of those living with HCV are unaware of their infection. Learn about new and recommended treatment options, education and management strategies, and how pharmacists can get more involved in the care of patients with HCV infection.

Pharmacist Learning Objectives

At the completion of this knowledge-based activity, participants will be able to:

  1. Identify important changes in recently updated guidelines that have the potential to influence the management of hepatitis C virus (HCV) infection.
  2. Describe clinically important drug updates, adverse effects, and drug-drug interactions associated with new drug classes used in the treatment of HCV infection.
  3. Outline strategies for improving patient adherence to drug therapy for HCV infection and reducing comorbidities.


This activity is supported by an independent educational grant from Gilead Sciences Inc.

Linda Spooner,
Paulina Deming, PHARMD
Associate Professor- Clinical Educator
University of New Mexico College of Pharmacy
Learning Level: Level 2
Track: Specialty Pharmacy, Clinical Patient Care and Services
Session Time Slot(s): 
Monday, March 19
1:00 PM - 2:30 PM
Music City Center - Room 101C-D
ACPE Pharmacist: 0202-0000-18-064-L01-P
CEUs Pharmacist: 0.15
Activity Type: